Vertex touts 13 percent revenue jump, beats profit estimates on strong cystic fibrosis performance
With a total revenue of nearly $2.7 billion, Vertex exceeded analyst estimates in the first quarter, bolstered by strong uptake of its cystic fibrosis products.